Population pharmacokinetics of imatinib in patients with pulmonary arterial hypertension

被引：0
|
作者：
Bouillon, Thomas [1 ]
Renard, Didier [1 ]
Zhou, Ping [2 ]
Flesch, Gerard [1 ]
Quinn, Debbie [3 ]
机构：
[1] Novartis Pharma AG, Modeling & Simulat, CH-4002 Basel, Switzerland
[2] Novartis Horsham Res Ctr, Drug Metab & Pharmacokinet, Horsham, W Sussex, England
[3] Novartis Pharmaceut, Crit Care, E Hanover, NJ USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2013年 / 42卷
关键词：
Pulmonary hypertension;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
556
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Efficacy of Imatinib Mesylate on Scleroderma Associated Pulmonary Arterial Hypertension
    Maki, H.
    Hatano, M.
    Yao, A.
    Imamura, T.
    Asada, K.
    Inaba, T.
    Shiga, T.
    Kinugawa, K.
    Nagai, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S212 - S213
  • [32] Pulmonary arterial hypertension in the elderly population
    Chen, Chang-Ying
    Hung, Cheng-Chung
    Chiang, Cheng-Hung
    Tsa, Yi-Ching
    Fu, Yun-Ju
    Wang, Chia-Lin
    Tsai, Fu-Ting
    Tai, Hsiao-Yun
    Lin, Kun-Chang
    Hung, Wan-Ting
    Kuo, Shu-Hung
    Huang, Wei-Chun
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2022, 85 (01) : 18 - 23
  • [33] EFFICACY OF IMATINIB MESYLATE ON SCLERODERMA ASSOCIATED PULMONARY ARTERIAL HYPERTENSION
    Maki, H.
    Hatano, M.
    Yao, A.
    Imamura, T.
    Inaba, T.
    Shiga, T.
    Kinugawa, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 238 - 239
  • [34] Imatinib in pulmonary arterial hypertension: c-Kit inhibition
    Farha, Samar
    Dweik, Raed
    Rahaghi, Franck
    Benza, Raymond
    Hassoun, Paul
    Frantz, Robert
    Torres, Fernando
    Quinn, Deborah A.
    Comhair, Suzy
    Erzurum, Serpil
    Asosingh, Kewal
    PULMONARY CIRCULATION, 2014, 4 (03) : 452 - 455
  • [35] First experiences with Imatinib for treatment of pulmonary arterial hypertension in collagenosis
    Rubbert, A.
    Draube, A.
    Owczarczyk, K.
    Faber, N.
    ten Freyhaus, H.
    Rosenkranz, S.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 : 68 - 68
  • [36] Safety, tolerability and pharmacokinetics of an intravenous bolus of sildenafil in patients with pulmonary arterial hypertension
    Vachiery, Jean-Luc
    Huez, Sandrine
    Gillies, Hunter
    Layton, Gary
    Hayashi, Naoto
    Gao, Xiang
    Naeije, Robert
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (02) : 289 - 292
  • [37] Efficacy, safety, and pharmacokinetics of inhaled treprostinil in Japanese patients with pulmonary arterial hypertension
    Kuwana, Masataka
    Abe, Kohtaro
    Kinoshita, Hideyuki
    Matsubara, Hiromi
    Minatsuki, Shun
    Murohara, Toyoaki
    Sakao, Seiichiro
    Shirai, Yuichiro
    Tahara, Nobuhiro
    Tsujino, Ichizo
    Takahashi, Kenta
    Kanda, Shingo
    Ogo, Takeshi
    PULMONARY CIRCULATION, 2023, 13 (01)
  • [38] Pharmacokinetics of Bosentan in Routinely Treated Japanese Pediatric Patients with Pulmonary Arterial Hypertension
    Taguchi, Masato
    Ichida, Fukiko
    Hirono, Keiichi
    Miyawaki, Toshio
    Yoshimura, Naoki
    Nakamura, Tsuneyuki
    Akita, Chisato
    Nakayama, Tomotaka
    Saji, Tsutomu
    Kato, Yuya
    Horiuchi, Isao
    Hashimoto, Yukiya
    DRUG METABOLISM AND PHARMACOKINETICS, 2011, 26 (03) : 280 - 287
  • [39] Modeling of pharmacokinetics, efficacy, and hemodynamic effects of macitentan in patients with pulmonary arterial hypertension
    Krause, Andreas
    Zisowsky, Jochen
    Dingemanse, Jasper
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2018, 49 : 140 - 146
  • [40] Pharmacokinetics of Oral Treprostinil in Children With Pulmonary Arterial Hypertension
    Hopper, Rachel K.
    Ivy, D. Dunbar
    Yung, Delphine
    Mullen, Mary P.
    Hanna, Brian D.
    Kirkpatrick, Edward
    Hirsch, Russel
    Austin, Eric D.
    Fineman, Jeffrey
    Solum, Derek
    Deng, C. Q.
    Feinstein, Jeffrey A.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2020, 76 (01) : 94 - 100
12345